Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT03657472
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 180
- Registration Number
- NCT03639480
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Bioequivalence Study of CJ-30060 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT03639493
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2018-05-31
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT03542916
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 203
- Registration Number
- NCT03536598
A Phase 1 Study of Tegoprazan on Healthy Male Volunteers
- First Posted Date
- 2018-05-21
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 44
- Registration Number
- NCT03530228
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Triple Therapy With Tegoprazan in H. Pylori Positive Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-13
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 284
- Registration Number
- NCT03498456
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT03378284
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2021-10-18
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 350
- Registration Number
- NCT03317223
- Locations
- 🇰🇷
Yonsei University Severance Hospital, Seoul, Korea, Republic of
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 210
- Registration Number
- NCT03231982
- Locations
- 🇰🇷
Yonsei University Severance Cardiovascular Hospital, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath